"ADP-Ribosylation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Post-translational modification of proteins with ADENOSINE DIPHOSPHATE RIBOSE.
    
			
			
				
				
					
						| Descriptor ID | D000074744 | 
					
						| MeSH Number(s) | G02.111.660.871.790.600.200 G02.111.691.600.200 G03.734.871.790.600.200 G05.308.670.600.200 | 
					
						| Concept/Terms | ADP-RibosylationADP-RibosylationADP-RibosylationsADP RibosylationADP RibosylationsRibosylation, ADPRibosylations, ADP(ADPRibosyl)ation(ADP-Ribosyl)ationADPRibosylationADPRibosylations
 Mono(ADP-Ribosyl)ationMono(ADP-Ribosyl)ationMARylationMARylationsMonoADPRibosylationMonoADPRibosylationsMono-ADPRibosylationMono-ADPRibosylationsMono ADPRibosylationADPRibosylation, MonoADPRibosylations, MonoMono ADPRibosylationsMono-ADP-RibosylationMono ADP RibosylationMono-ADP-RibosylationsMono(ADPRibosyl)ation
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "ADP-Ribosylation".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "ADP-Ribosylation".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "ADP-Ribosylation" by people in this website by year, and whether "ADP-Ribosylation" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2018 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "ADP-Ribosylation" by people in Profiles.
						
					
								- 
								Bi-allelic ADPRHL2 Mutations Cause Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy. Am J Hum Genet. 2018 11 01; 103(5):817-825. 
- 
								EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer. Oncogene. 2018 01 11; 37(2):208-217.